
Optune Pax: TTFields FDA Approval for Pancreatic Cancer
Review the 2026 FDA approval of Optune Pax (TTFields) for locally advanced pancreatic cancer. Explore PANOVA-3 trial survival data and mechanism of action.

Review the 2026 FDA approval of Optune Pax (TTFields) for locally advanced pancreatic cancer. Explore PANOVA-3 trial survival data and mechanism of action.
© 2026 IntuitionLabs. All rights reserved.